These data provided conclusive evidence that FcRn enables cross-presentation of IgG-complexed antigens downstream of FcγR and that this is a physiologically meaningful process, which is active in initiating immune responses to low doses of antigen in the early stages of infection. The gene discussed is FCGRT; the disease is infection.